When was Harmonic Discovery founded?

Harmonic Discovery was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Harmonic Discovery located?

Harmonic Discovery is headquartered in New York City, United States.

Who is the current CEO of Harmonic Discovery?

Rayees Rahman of Harmonic Discovery. They have also founded 2 companies.

How many employees does Harmonic Discovery have?

As of Dec 31, 2022, Harmonic Discovery has 7 employees, reflecting a 134% year-over-year growth in headcount.

Is Harmonic Discovery a funded company?

Harmonic Discovery is a funded company, having raised a total of $8.12M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

When was the latest funding round of Harmonic Discovery?

Harmonic Discovery's latest funding was a $***** Seed round on Sep 08, 2022, with participation from 5 investors. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $605M in funding in 2026 to date.

Where does Harmonic Discovery rank among its competitors?

Harmonic Discovery ranks 690th amongst 3224 active competitors, of which 1103 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Moderna, which secured $590M in Jan, 2025.

Who are the top competitors of Harmonic Discovery?

Harmonic Discovery's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics. Among them, Moderna secured the most recent funding round in January, 2025.

Harmonic Discovery - 2026 Company Profile, Team, Funding & Competitors

Harmonic Discovery is a seed company based in New York City (United States), founded in 2021 by Rayees Rahman, Marcel Patek and Jason Lee. It operates as a Developer of kinase inhibitor drugs for oncology. Harmonic Discovery has raised $8.12M in funding from Y Combinator and Innovation Endeavors. The company has 3224 active competitors, including 1103 funded and 770 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics.

Company Details

Developer of kinase inhibitor drugs for oncology. The company's platform integrates biological screening and medicinal chemistry with computational chemistry to predict clinical resistance mutations and optimize the design of small molecule therapeutics to maintain binding to their key targets and avoid harmful off-target interactions, enabling medical practitioners to treat cancer more effectively.

Website: www.harmonicdiscovery.com
Social

Key Metrics

Founded Year

2021

Location

New York City, United States

Stage

Seed

Total Funding

$8.12M in 2 rounds

Latest Funding Round

Seed, Sep 08, 2022, $*****

Investors

Y Combinator & 4 more

Ranked

690^th among 3224 active competitors

Employee Count

7 as on Dec 31, 2022

Similar Companies

Jazz Pharmaceuticals & 2980 more

View Harmonic Discovery's full profile

Harmonic Discovery is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
HARMONIC DISCOVERY CIN: 86-3992171 , United States, Active	Mar 15, 2022	-	7 (As on Dec 31, 2022)	-

Harmonic Discovery has raised a total funding of $8.12M over 2 rounds. Its first funding round was on 2021. Its latest funding round was a Seed round on Sep 08, 2022 for $*****. 5 investors participated in its latest round. Harmonic Discovery has 5 institutional investors.

Here is the list of recent funding rounds of Harmonic Discovery:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 08, 2022	4222777	Seed	3343038	3612486	7375145	3462330
2021	6753	Seed	2437	2860	Y Combinator	2945

Access funding benchmarks and valuations. Sign up today!

View details of Harmonic Discovery's funding rounds and investors

The founders of Harmonic Discovery are Rayees Rahman, Marcel Patek and Jason Lee. Rayees Rahman is the CEO of Harmonic Discovery.

Here are the details of Harmonic Discovery's key team members:

Rayees Rahman: Co-Founder & CEO of Harmonic Discovery and founder of 1 other company.
Contact Info: 1 email address
Marcel Patek: Co-Founder & CSO of Harmonic Discovery.
Contact Info: 1 email address
Jason Lee: Co-Founder & COO of Harmonic Discovery.
Contact Info: 1 email address

View details of Harmonic Discovery's Founder profiles and Board Members

Harmonic Discovery's employee count trend

Harmonic Discovery has 7 employees as of Dec 22. The total employee count is 133.0% more than what it was in Dec 21. Here is Harmonic Discovery's employee count trend over the years:

Employee count trend for Harmonic Discovery

Uncover Harmonic Discovery's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Harmonic Discovery include Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics. Here is the list of Top 10 competitors of Harmonic Discovery, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, KKR & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of genetically engineered cell therapies for multiple disorders	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
3rd	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	74/100
4th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Third Rock Ventures, Nextech Invest & 20 others	73/100
5th	Kronos Bio 2017, San Mateo (United States), Acquired	Developer of small molecule based therapeutics for cancer treatment	$271M	Omega Funds, Vida Ventures & 18 others	72/100
6th	BeiGene 2010, Cambridge (United States), Public	Developer of targeted and immune-oncology drugs against cancer	$172M	Hillhouse, Boxer Capital & 13 others	72/100
7th	MacroGenics 2000, Rockville (United States), Public	Developer of novel biologics for the treatment of autoimmune disorders, cancer and infectious disease	$126M	Nextech Venture, Ventures West & 29 others	72/100
8th	Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public	Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others	-	BB Biotech, Kaccelerator & 7 others	71/100
9th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, Astrazeneca & 31 others	71/100
10th	Harbour BioMed 2016, Shanghai (China), Public	Developer of antibody therapeutics in immunology and oncology disease	$313M	GIC, Hudson Bay Capital & 19 others	71/100
690th	Harmonic Discovery 2021, New York City (United States), Seed	Developer of kinase inhibitor drugs for oncology	$8.12M	Innovation Endeavors, Fifty Years & 3 others	48/100